Key facts
- This page summarizes Laura A. Francis's Form 4 filing for SI-BONE, Inc. (SIBN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Nov 2026, 17:02.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated June 13, 2025.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $25.00 USD to $25.90 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
Shares held by The David & Laura Joint Rev Tr.
Footnote F4
Includes 355,697 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.